Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures

Journal of Crohn's and Colitis

Volumn 6, Issue 5, 2012, Pages 507-517

  Achleitner, Ulrike ^a   Coenen, Michaela ^a   Colombel, Jean Frédéric ^b   Peyrin Biroulet, Laurent ^c   Sahakyan, Narine ^a   Cieza, Alarcos ^a,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d ICF Research Branch in cooperation with the WHO   (Germany)

Author keywords

Crohn disease; Inflammatory bowel diseases; International Classification of Functioning, Disability and Health; Review; Systematic; Ulcerative colitis

Indexed keywords

CLEVELAND GLOBAL QUALITY OF LIFE; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; ENTERITIS; FLATULENCE; HEALTH PRACTITIONER; HEALTH STATUS; HUMAN; INFLAMMATORY BOWEL DISEASE QUALITY OF LIFE QUESTIONNAIRE; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 32; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 9; INFLAMMATORY BOWEL DISEASE STRESS INDEX; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; LEISURE; MEDICAL RESEARCH; PATIENT REPORTED OUTCOME MEASURE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING FORM OF INFLAMMATORY BOWEL DISEASE PATIENT CONCERN; RECREATION; REVIEW; SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; SYSTEMATIC REVIEW;

ACTIVITIES OF DAILY LIVING; DISABILITY EVALUATION; DISABLED PERSONS; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATORY BOWEL DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; SELF REPORT; WORLD HEALTH ORGANIZATION;

EID: 84860842137     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.11.003     Document Type: Review

References (48)

1. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflamm Bowel Dis 2011, 17:471-478.
2. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 05:89-297.
3. Carter M.J., Lobo A.J., Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53(Suppl V):V1-V16.
4. Ghosh S., Shand A., Ferguson A. Ulcerative colitis. Br Med J 2000, 320:1119-1123.
5. Martins N.B., Peppercorn M.A. Inflammatory bowel disease. Am J Manag Care 2004, 10:544-552.
6. Rubin D., Dubinsky M., Pannaccione R., Siegel C., Binion D., Kane S., Hopper J. The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci 2010, 55:1044-1052.
7. Ananthakrishnan A., Weber L., Knox J., Skaros S., Emmons J., Lundeen S., Issa M., Otterson M., Binion D. Permanent work disability in Crohn's disease. Am J Gastroenterol 2008, 103:154-161.
8. Rogola L., Miller N., Graff L., Rawsthoren P., Clara I., Walker J., Lix L., Ediger J., McPhail C., Bernstein C. Population-based controlled study of social support, self-perceived stress, activity and work issue, and access to health care in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:526-535.
9. Cohen R.D. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther 2002, 16:1603-1609.
10. Love J.R., Irvine E.J., Fedorak R.N. Quality of life in inflammatory bowel disease. J Clin Gastroeterol 1992, 14:15-19.
11. D'Haens G., Sandborn W., Feagan B., Geboes K., Hanauer S., Irvine E., Lémann M., Marteau P., Rutgeerts P., Schölmerich J., Sutherland L. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132:763-786.
12. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
13. Harvey R.F., Bradshaw J.M. A simple index of Crohn's disease activity. Lancet 1980, 1:514.
14. Peyrin-Biroulet L., Cieza A., Sandborn W., Kostanjesk N., Kamm M., Toshifumi H., Lémann M., Stucki G., Colombel J.F. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis 2010, 16:15-22.
15. Reichel C., Streit J., Wunsch S. Linking Crohn's disease health status measurements with International Classification of Functioning, Disability and Health and vocational rehabilitation outcomes. J Rehabil Med 2010, 42:74-80.
16. Guyatt G., Mitchell A., Irvine E.J., Singer J., Williams N., Goodacre R., Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
17. Drossman D.A., Leserman J., Li Z.M., Mitchell C.M., Zagami E.A., Patrick D.L. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med 1991, 53:701-712.
18. Joachin G., Milne B. Inflammatory bowel disease: effects on lifestyle. J Adv Nurs 1987, 12:483-487.
19. WHO International Classification of Functioning, Disability and Health (ICF) 2001, World Health Organization, Geneva.
20. Cieza A., Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res 2005, 14:1225-1237.
21. Geyh S., Cieza A., Kollerits B., Grimby G., Stucki G. Content comparison of health-related quality of life measures used in stroke based on the International Classification of Functioning, Disability and Health (ICF): a systematic review. Qual Life Res 2007, 16:833-851.
22. Escorpizo R., Finger M.E., Glässel A., Gradinger F., Lückenkemper M., Cieza A. A systematic review of functioning in vocational rehabilitation using the International Classification of Functioning, Disability and Health. J Occup Rehabil 2011, 21:134-146.
23. Cieza A., Brockow T., Ewert T., Amman E., Kollerits B., Chatterji S., Üstün T.B., Stucki G. Linking health-status measurements to the International Classification of Functioning, Disability and Health. J Rehabil Med 2002, 34:205-210.
24. Cieza A., Geyh S., Chatterji S., Kostanjsek N., Üstün B., Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med 2005, 37:212-218.
25. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20:37-46.
26. Vierkant R.A.A. SAS macro for calculating bootstrapped confidence intervals about a kappa coefficient (Accessed August 31, 2010 at. http://www2.sas.com/proceedings/sugi22/STATS/PAPER295.PDF.
27. Fazio V.W., O'Riordain M.G., Lavery I.C., Church J.M., Lau P., Strong S.A., Hull T. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 1999, 230:575-584.
28. Love J.R., Irvine E.J., Fedorak R.N. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992, 14:15-19.
29. Alcalá M.J., Casellas F., Prieto L., Malagelada J.R. Development of a short questionnaire for quality of life specific for inflammatory bowel disease. Gastroenterology 2001, 120(Suppl1):A450.
30. Alcalá M.J., Casellas F., Fontanet G., Prieto L., Malagelada J.R. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis 2004, 10:383-391.
31. Irvine E.J., Zhou Q., Thompson A.K. CCRPT Investigators. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996, 91:1571-1578.
32. Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993, 4:353-365.
33. Baumgart D.C., Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-1657.
34. De Rooy E.C., Toner B.B., Maunder R.G., Greenberg G.R., Baron D., Steinhart H., McLeod R., Cohen Z. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001, 96:1816-1821.
35. Bielefeldt K., Davis B., Binion D.G. Pain and inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:778-788.
36. Lix L.M., Graff L.A., Walker J.R., Clara I., Rawsthorne P., Rogala L., Miller N., Ediger J., Pretorius T., Bernstein C.N. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1575-1584.
37. Muller K.R., Prosser R., Bampton P., Mountifield R., Andrews J.M. Female gender and surgery impair relationships, body image and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis 2010, 16:657-663.
38. Ranjbaran Z., Keefer L., Farhadi A., Stepanski E., Sedghi S., Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol 2007, 22:1748-1753.
39. Alvarez G.G., Ayas N.T. The impact of daily sleep duration on health: a review of literature. Prog Cardiovasc Nurs 2004, 9:56-59.
40. Stjernman H., Tysk C., Almer S., Ström M., Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand J Gastroenterol 2010, 45:696-706.
41. Peyrin-Biroulet L., Cieza A., Sandborn W., Coenen M., Chowers Y., Hibi T., Stucki G., Colombel J.F. Development of the disability index for inflammatory bowel disease based on the International Classification of Functioning, Disability and Health. Gut 2011, published online Jun 5 DOI: 2011-300049.R1.
42. Ware J.E., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
43. Spitzer W.O., Dobson A.J., Hall J., Chesterman E., Levi J., Shepherd R., Battista R.N., Catchlove B.R. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981, 34:585-597.
44. The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998, 28:551-558.
45. Ustün T.B., Chatterji S., Kostanjsek N., Rehm J., Kennedy C., Epping-Jordan J., Saxena S., von Korff M., Pull C. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ 2010, 88:815-823.
46. Hunt S.M., McEwen J., McKenna S.P. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985, 35:185-188.
47. McColl E., Han S.W., Barton J.R., Welfare M.R. A comparison of the discriminatory power of the inflammatory bowel disease questionnaire and the SF-36 in people with ulcerative colitis. Qual Life Res 2004, 13:805-811.
48. Sands B.E., Abreu M.T., Ferry G.D., Friffiths A.M., Hanauer S.B., Isaacs K.L., Lewis J.D., Sandborn W.J., Steinhart A.H. Design issues and outcomes in IBD clinical trials. Inflamm Bowel Dis 2005, 11(Suppl1):S22-S28.